
Longboard Pharmaceuticals Investor Relations Material
Latest events

Q2 2024
Longboard Pharmaceuticals
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Longboard Pharmaceuticals Inc
Access all reports
Longboard Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company primarily focused on developing innovative therapies for neurological diseases. Leveraging its expertise in G protein-coupled receptor (GPCR) technology, Longboard Pharmaceuticals aims to create transformative treatments for these conditions. The company's product candidates are designed to be highly selective with the potential to offer significant improvements over existing therapies. Notably, the company was founded as a spin-off from Arena Pharmaceuticals in 2020 to further advance these specialized drug candidates. The company is headquartered in La Jolla, California, and its shares are listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
LBPH
Country
🇺🇸 United States